Craig Jalbert

Ibis Technology Corp. develops, manufactures and markets SIMOX-SOI implantation equipment for the worldwide semiconductor industry. SIMOX creates an insulating oxide barrier below the top surface of a silicon wafer through implantation and annealing. The company's proprietary oxygen implanters produce SIMOX-SOI wafers by implanting oxygen atoms just below the surface of a silicon wafer to create a very thin layer of silicon dioxide between the thin operating region of the transistor at the surface and the underlying silicon wafer itself. It was founded in October 1987.

Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA.

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA.

CompuCyte Corp. develops laser scanning products. Its comprehensive line of laser scanning cytometry instrumentation is applied to automated cellular and tissue analysis in life science research, drug safety, toxicology studies and clinical trials. The company was founded by Louis A. Kamentsky in 1992 and is headquartered in Westwood, MA.

SIONEX Corp. develops chemical and biological sensor chips and systems. The company was founded in 2001 and is headquartered in Bedford, MA.

Agritech Worldwide, Inc. is an agricultural technology company, which engages in the sale of a line of all-natural products. The firm develops new commodities and processes that transform agricultural by products into multi functional ingredients used in food manufacturing and other industries. Its products include Z Trim and Oat Z Trim. The company was founded on May 5, 1994 and is headquartered in New York, NY.

MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.

Verdolino & Lowey PC is a professional services firm that provides accounting, tax, and consulting services to individuals and businesses. The private company is based in Foxborough, MA. The company offers a range of services, including tax planning and preparation, financial statement preparation, bookkeeping, and business consulting. The company serves clients in various industries, including healthcare, real estate, construction, and retail.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.